Patents by Inventor Ala Azhari

Ala Azhari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Epigenetic modification of fungi and uses thereof
    Patent number: 12180524
    Abstract: Described herein are methods of epigenetic modification of fungi and uses thereof. Also described herein are compounds that can have antileishmanial activity and formulations thereof. Also described herein are methods of treating leishmanial infection in a subject that include the step of administering a compound or formulation thereof described herein to the subject.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: December 31, 2024
    Assignees: UNIVERSITY OF SOUTH FLORIDA, INSTITUTO POLITÉCNICO NACIONAL, KING ABDULAZIZ UNIVERSITY
    Inventors: Bill J. Baker, Dennis E. Kyle, Mario Alberto Rodriguez-Pérez, Anne-Claire D. Limon, Ala Azhari
  • EPIGENETIC MODIFICATION OF FUNGI AND USES THEREOF
    Publication number: 20220136019
    Abstract: Described herein are methods of epigenetic modification of fungi and uses thereof. Also described herein are compounds that can have antileishmanial activity and formulations thereof. Also described herein are methods of treating leishmanial infection in a subject that include the step of administering a compound or formulation thereof described herein to the subject.
    Type: Application
    Filed: August 18, 2021
    Publication date: May 5, 2022
    Inventors: Bill J. Baker, Dennis E. Kyle, Mario Alberto Rodriguez-Pérez, Anne-Claire D. Limon, Ala Azhari
  • Antimicrobials from an epigenetics based fungal metabolite screening program
    Patent number: 10377733
    Abstract: Novel antimicrobial compounds against drug targets such as Eskape pathogens, Leishmania donovani, Mycobacterium tuberculosis, Clostridium difficile, Naegleria fowleri, and cancer are presented herein.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: August 13, 2019
    Assignees: University of South Florida, King Abdulaziz University
    Inventors: Danielle H. Demers, Bill J. Baker, Ala Azhari, Renee M. Fleeman, Dennis E. Kyle, Lindsey Neil Shaw
  • Antimicrobials from an epigenetics based fungal metabolite screening program
    Patent number: 10358431
    Abstract: Novel antimicrobial compounds against drug targets such as Eskape pathogens, Leishmania donovani, Mycobacterium tuberculosis, Clostridium difficile, Naegleria fowleri, and cancer are presented herein.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: July 23, 2019
    Assignees: University of South Florida, King Abdulaziz University
    Inventors: Danielle H. Demers, Bill J. Baker, Ala Azhari, Renee M. Fleeman, Dennis E. Kyle, Lindsey Neil Shaw
  • Antimicrobials from an epigenetics based fungal metabolite screening program
    Patent number: 10144719
    Abstract: Novel antimicrobial compounds against drug targets such as Eskape pathogens, Leishmania donovani, Mycobacterium tuberculosis, Clostridium difficile, Naegleria fowleri, and cancer are presented herein.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: December 4, 2018
    Assignee: University of South Florida
    Inventors: Danielle H. Demers, Bill J. Baker, Ala Azhari, Renee M. Fleeman, Dennis E. Kyle, Lindsey Neil Shaw